Zurich Cantonal Bank
ARQT icon

Zurich Cantonal Bank’s Arcutis Biotherapeutics ARQT Stock Holding History

Zurich Cantonal Bank’s Portfolio ARQT Stock Details ARQT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$993K Buy
42,131
+5,072
+14% +$129K ﹤0.01% 1438
2025
Q4 		$1.08M Sell
37,059
-39,122
-51% -$1M ﹤0.01% 1297
2025
Q3 		$1.44M Buy
76,181
+46,616
+158% +$735K ﹤0.01% 1089
2025
Q2 		$415K Sell
29,565
-132
-0.4% -$1.85K ﹤0.01% 1770
2025
Q1 		$464K Buy
29,697
+917
+3% +$12.9K ﹤0.01% 1642
2024
Q4 		$401K Buy
28,780
+10,018
+53% +$110K ﹤0.01% 1766
2024
Q3 		$174K Hold
18,762
– – ﹤0.01% 2183
2024
Q2 		$174K Buy
+18,762
New +$170K ﹤0.01% 2106
2023
Q4 		– Sell
-6,060
Closed -$32.2K – 2731
2023
Q3 		$32.2K Sell
6,060
-1
-0% -$9 ﹤0.01% 2667
2023
Q2 		$57.8K Hold
6,061
– – ﹤0.01% 2565
2023
Q1 		$66.7K Sell
6,061
-965
-14% -$14K ﹤0.01% 2501
2022
Q4 		$104K Buy
7,026
+1,134
+19% +$19.8K ﹤0.01% 2241
2022
Q3 		$113K Buy
5,892
+4,530
+333% +$103K ﹤0.01% 2116
2022
Q2 		$29K Sell
1,362
-132
-9% -$2.71K ﹤0.01% 2730
2022
Q1 		$29K Buy
+1,494
New +$25.3K ﹤0.01% 2612

Other funds holding ARQT

SCM
Suvretta Capital Management New York $3.69B AUM 86.67% 1-Year Est. Return
FLSM
Frazier Life Sciences Management Palo Alto, California $3.89B AUM 201.1% 1-Year Est. Return
BlackRock
BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return
RCMNY
Rubric Capital Management (New York) New York $8.16B AUM 68.42% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
PCH
Polar Capital Holdings London, United Kingdom $22.9B AUM 115.26% 1-Year Est. Return
Jennison Associates
Jennison Associates New York $145B AUM 34.61% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
GGHC
Gilder Gagnon Howe & Co New York $8.34B AUM 46.58% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return